Group Brief Cognitive-Behavioral Therapy (G-BCBT) for Suicidal Ideation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Naval Medical Center Portsmouth, Portsmouth, VA
Suicidal Ideation+6 More
Group Brief Cognitive-Behavioral Therapy (G-BCBT) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will evaluate a group therapy intervention for suicide ideation, ability to use coping strategies, and mental health. The group therapy intervention will be delivered via a 12-session group therapy treatment and is expected to be no worse than an existing gold standard intervention. G-BCBT is used to treat Suicidal Ideation and has been previously approved by the FDA for a different condition. No patients in this trial will receive a placebo.

Eligible Conditions

  • Suicidal Ideation
  • Parasuicide
  • Skills, Coping
  • Anxiety
  • Depression
  • Post Traumatic Stress Disorder (PTSD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: From pre-intervention baseline to 3- and 6-months post-treatment completion.

From pre-intervention baseline to 3- and 6-months post-treatment completion.
Change in Beck Scale for Suicidal Ideation score
Change in Patient Health Questionnaire-9 score
Frequency of suicide attempts

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

DBT
1 of 2
G-BCBT
1 of 2
Active Control
Experimental Treatment

136 Total Participants · 2 Treatment Groups

Primary Treatment: Group Brief Cognitive-Behavioral Therapy (G-BCBT) · No Placebo Group · N/A

G-BCBT
Behavioral
Experimental Group · 1 Intervention: Group Brief Cognitive-Behavioral Therapy (G-BCBT) · Intervention Types: Behavioral
DBT
Behavioral
ActiveComparator Group · 1 Intervention: Dialectical Behavior Therapy (DBT) Skills Group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: from pre-intervention baseline to 3- and 6-months post-treatment completion.
Closest Location: Naval Medical Center Portsmouth · Portsmouth, VA
Photo of virginia 1Photo of virginia 2Photo of virginia 3
2005First Recorded Clinical Trial
1 TrialsResearching Suicidal Ideation
23 CompletedClinical Trials

Who is running the clinical trial?

University of North Carolina, CharlotteLead Sponsor
18 Previous Clinical Trials
2,516 Total Patients Enrolled
Ohio State UniversityOTHER
693 Previous Clinical Trials
375,170 Total Patients Enrolled
4 Trials studying Suicidal Ideation
530 Patients Enrolled for Suicidal Ideation
United States Naval Medical Center, PortsmouthFED
30 Previous Clinical Trials
4,169 Total Patients Enrolled
Robert J Cramer, PhDPrincipal InvestigatorUNC Charlotte

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be at least 18 years-of-age to donate blood.
You are able to give informed consent.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.